An Open Label Study of the Effects of SHR1459 in NMOSDs Patients

Clinical trial NCT04670770 · COMPLETED

Trial details

NCT number: NCT04670770
Sponsor: Reistone Biopharma Company Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuromyelitis Optica Spectrum Disorders

Start date: 2021-01-20
Primary completion: 2022-08-15
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.